Phathom Pharmaceuticals price target raised to $29 from $23 at Cantor Fitzgerald
Cantor Fitzgerald raised the firm's price target on Phathom Pharmaceuticals (PHAT) to $29 from $23 and keeps an Overweight rating on the shares. The FDA has granted Phathom Pharmaceuticals 10-year exclusivity for Voquenza, which extends the exclusivity period to May 2032 instead of 2030, adding about $6 per share to the firm's distributable cash flow estimates, the analyst tells investors in a research note. Cantor says the overhang has been removed and continues to view Voquenza as a 'great' drug in the acid-suppression space with more room to grow.
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Cantor Says These 2 SaaS Stocks Are Top Picks as AI Rewrites the Software Playbook
AI and cloud services have already made their mark on the tech landscape, and the next iteration is taking shape: artificial intelligence software as a service, or AI SaaS. Simply put, it refers to the use of cloud technology to deliver advanced AI tools while minimizing cost and resource demands for end users. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The cloud can already reach a wide range of customers, users who require high-end computing but can't support the infrastructure themselves. Adding AI to the mix will put advanced functions – think machine learning and natural language processing – into the cloud's toolbox. From a user perspective, putting AI tools into the subscription-based SaaS model will also give advantages in flexibility and scalability. The opportunity here is substantial. According to Zion Market Research, last year, the AI SaaS market was estimated to be worth $115.22 billion – and it's predicted to see a CAGR of 38% or more over the next decade, to reach $2.97 trillion by 2034. Covering the AI/SaaS segment from Cantor, analyst Matthew VanVliet sees major upside in this space – and in the stocks poised to benefit. 'We believe there is ample upside for the group ahead, as AI represents a much greater catalyst than anything in the past couple of years, more significant and sustainable than pandemic-era work-from-anywhere investments. Our view is the opportunity for growth to re-accelerate points to upside for the AI winners, unlocking multiple expansion if this plays out as we are expecting,' VanVliet opined. Building on that bullish outlook, the analyst has singled out two top picks he believes are especially well-positioned to ride this next wave of AI-driven growth – a view echoed by the broader analyst community. According to the TipRanks database, both stocks carry Strong Buy consensus ratings from the Street. Let's take a closer look. Klaviyo, Inc. (KVYO) The first company we'll look at here is Klaviyo, a software firm that brings CRM (customer relationship management) to the B2C world. The company fields a proprietary data platform with AI insights, to give its customers effective marketing automation, data analysis, and customer service. The aim here is personalized service – Klaviyo's customers can use the company's software packages to improve their own customers' interactions: customer profiles, omnichannel campaigns, web forms, and more. Klaviyo has built its operations and reputation on the quality of its data-based services – which positioned the company well to integrate AI into its offerings. The company's email and SMS marketing services already make use of AI tech to smooth out customization and targeting, to automate content generation, and to optimize send times. Klaviyo's clean data library is a key support for the AI services. Strong services have allowed this company to build a solid customer base. In its last financial release, Klaviyo defined a customer as 'a distinct paid subscription to our platform;' by that definition, the company stated that it had over 169,000 customers as of this past March 31. Within that customer base, the number of large customers – defined as those generating more than $50,000 in annual recurring revenue (ARR) came to 3,030, up 40% year-over-year. In addition to building a strong customer base, Klaviyo's 1Q25 financial release also showed quarterly revenue of $279.8 million, up 33% year-over-year and $11.89 million ahead of the forecasts. The company ran a net loss in the quarter, of 5 cents per share, but that was one cent per share better than had been anticipated. Turning to Cantor's VanVliet, we find the analyst upbeat on Klaviyo, citing the company's strong position and its large total addressable markets and potential for growth. He writes of the stock, 'KVYO's core ecommerce/retail SAM is ~$16b, with a clear eye to more of the market as the platform expands, uptake of its CRM increases, such that it becomes a true system of record, and AI broadens its reach. KVYO's TAM also keeps expanding as it moves upmarket and diversifies across new industries and geographies. Within the US, it sizes the TAM at $34b and the global opportunity at $68b. At $1b+ of revenue today, KVYO's penetration remains low, providing it a long runway of potential future growth.' VanVliet's comments back up his Overweight (i.e., Buy) rating here, and his $48 price target implies a potential gain of 41% for the shares in the year ahead. (To watch VanVliet's track record, click here) The Strong Buy consensus rating on KVYO shares is based on 18 recent Wall Street recommendations, which break down to 15 Buys and 3 Holds. The stock's $33.95 current trading price and $43.41 average target together suggest a one-year upside of 28%. (See KVYO stock forecast) HubSpot, Inc. (HUBS) Next on our list of Cantor's Top Picks is HubSpot, the well-known marketing software platform. The company has a reputation for innovation and has developed a solid stable of marketing software packages offered through a unified platform. HubSpot's software solves problems and smooths out processes in CRM, content management, social media management, and SEO – in fact, in pretty much any area of online direct marketing, inbound sales, and customer service. HubSpot introduced its Breeze AI toolkit last year as an AI enhancement of the company's existing services – and as an independent set of AI-powered marketing tools. The company's Breeze Customer Agent is billed as a '24/7 AI concierge,' capable of independently automating features in marketing, sales, and service. The system is designed to act on the human operator's instruction, with the AI agent handling the implementation. HubSpot claims that client teams using the AI agent see a 10% higher close rate on work orders, a 39% faster ticket resolution, and upwards of 50% of customer contact conversations resolved automatically – with the top users reaching 90%. In addition to streamlining marketing outreach, HubSpot also makes AI systems available in the content field. The company's Breeze Content Agent can scale content marketing efforts, create and publish landing pages, and generate search-optimized blog posts – and all in minutes rather than hours. The AI can even handle scripting and voiceover for video content. In its 1Q25 financial report, HubSpot reported what it described as a 'solid start' to the year. The company's customer count as of March 31 was up 19% year-over-year, a growth figure that offset a 4% decline in average subscription revenue per customer. At the top line, HubSpot reported $714.1 million in revenue, up 16% year-over-year and $13.7 million ahead of the pre-release estimates. HubSpot runs a quarterly profit, and in Q1 it realized a non-GAAP EPS of $1.84 – 8 cents better than expected. The company finished Q1 with $2.2 billion in cash and liquid assets on hand. Checking in again with VanVliet and the Cantor view of this CRM firm, we find him impressed by HubSpot's record of success. The analyst says of the company, 'HUBS is one of the few CRM industry players that has successfully moved into adjacent sub-categories (started in Marketing, expanded to Sales, Service, Content, and increasingly Commerce). We think this is a testament to HUBS's mgmt., which we view as best-of-breed. By methodically building the platform breadth and depth, HUBS is now gaining traction upmarket, which is key to sustaining mid-to-high teens growth over the medium term. HUBS is also building a more robust partner network, which is further accelerating upmarket traction.' Looking ahead, and specifically looking at HubSpot's use of AI to chart a new path ahead, the Cantor analyst remains upbeat, adding to his comments above, 'HUBS' organically built platform is well-positioned to leverage AI and strengthen its competitive edge. Breeze AI is already driving higher Content Hub attach rates (tripled y/y in 1Q). Further, we think Breeze will play an important role in unlocking Service Hub traction, which is critical to HUBS' next leg of growth.' Unsurprisingly, VanVliet rates HUBS stock as Overweight (i.e., Buy). His price target, set at $775, indicates room for an upside potential of 28.5% on the one-year horizon. HubSpot has picked up 28 recent analyst recommendations, which include 24 to Buy against just 4 to Hold, for a Strong Buy consensus rating. The stock is selling for $602.61, and its $749.32 average price target implies a potential one-year gain of 24%. (See HUBS stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The Hill
7 hours ago
- The Hill
Why Musk's feud with Trump could jeopardize his business empire
Elon Musk, the world's richest man, may have made himself an enemy of the world's most powerful leader. The public blowout between Musk and President Trump is threatening the tech billionaire's businesses, some of which have billions of dollars' worth of federal contracts. Musk's aerospace company SpaceX alone reportedly has at least $22 billion in federal contracts — which Trump had threatened to revoke at the peak of his feud with his former adviser. 'Trump goes after people, companies and organizations he doesn't like,' said Peter Loge, a professor at George Washington University and former senior FDA adviser during the Obama administration. 'As a real estate developer, politician and president, he has used every tool at his disposal to punish people he thinks have wronged him,' Loge added. 'Unless Musk expresses contrition, Trump is likely to hurt him in every way he can think of. If Musk is contrite, he can be welcomed back into the Trump tent.' While the two could reconcile in the future, observers agree the dramatic turn of events leaves Musk's business empire vulnerable to Trump's wrath. Trump, at one point during Thursday's back-and-forth, threatened to cut Musk's government contracts as he called his former adviser 'crazy.' 'The easiest way to save money in our Budget, Billions and Billions of Dollars, is to terminate Elon's Governmental Subsidies and Contracts. I was always surprised that Biden didn't do it!' Trump wrote in a Truth Social post. Musk, in turn, said he would decommission SpaceX's Dragon spacecraft, which is responsible for ferrying astronauts and cargo to and from the International Space Station. He later backed off, after an X user urged him to 'cool off and take a step back.' The exchange underscored how Musk's business ventures could get caught in the crosshairs of any feud with the president, who is known to have a proclivity for retribution. 'If this turns into a hot war, certainly, the consequences for Musk's business relationship with the federal government could be in peril, or at least significantly complicated,' said GOP strategist and Trump campaign alum Brian Seitchik. The tech billionaire officially departed the White House last week after a four-month stint in government in which he seemed to rarely leave Trump's side, becoming a near constant presence at Mar-a-Lago, Cabinet meetings and the Oval Office. He exited the administration seemingly on good terms with Trump despite his pushback against the president's sweeping tax and spending bill — the centerpiece of Trump's domestic policy agenda, which is projected to add trillions of dollars to the deficit. Trump presented Musk with a golden key to the White House during a Friday farewell ceremony in Oval Office, during which the duo downplayed their differences and spoke highly of each other's work. However, Musk sharpened his criticism of Trump's 'big, beautiful bill' soon after, as he slammed the legislation as a 'disgusting abomination.' The president responded Thursday, saying he was 'very surprised' and 'disappointed' by Musk's comments and cast doubt on the future of their relationship. 'Elon and I had a great relationship. I don't know if we will anymore,' Trump said during an Oval Office appearance alongside German Chancellor Friedrich Merz. The situation quickly devolved into personal attacks. Musk fired back on his social platform X, suggesting the president would have lost the 2024 election without him, linking Trump to disgraced financier Jeffrey Epstein and backing calls for the president's impeachment. As the feud dragged on Thursday, Tesla's stock plunged 14 percent Thursday, costing the electric vehicle maker more than $150 billion. The company was still trying to fully recover from the fallout of Musk's highly controversial role in the Trump administration, leading the Department of Government Efficiency (DOGE). Tesla's stock is down 20 percent since the start of the year. 'The social media and war of words back and forth is not good for anyone and put massive pressure on Tesla shares with fears that Trump will turn from friend to foe and create a tough regulatory environment for Musk in the Beltway,' Wedbush Securities analysts wrote in a note Friday. 'Musk needs Trump and Trump needs Musk for many reasons, and these two becoming friends again will be a huge relief for Tesla shares,' they added. Ross Gerber, a longtime Tesla investor and CEO of Gerber Kawasaki Wealth and Investment Management, slammed Musk for the ripple effects his comments may have had on Tesla's stock. 'Trump is an angry and vindictive man who doesn't forget when slighted. This doesn't get solved other than Elon groveling back and publicly apologizing,' Gerber wrote on X Friday, adding in an earlier post, 'So Tesla investors are down $140 billion over this break up. About how much Musk claimed to saving for the US government.' As the back-and-forth unfolded Thursday, Gerber quipped, 'Can someone please take the phone away from him [Musk].' When pressed on the feud, White House press secretary Karoline Leavitt said Musk has a right to speak for his companies. 'So the only difference between Friday and today is Elon went back to his companies. And, as a businessman, he has a right to speak for his companies. But as president, President Trump has a responsibility to fight for this country,' she said Thursday on FOX News Channel's 'Hannity.' While Trump could pose new risks to Musk's business outlooks, analysts say the fight could also impede the president's ability to run the government. SpaceX held federal contracts with agencies like NASA and the Pentagon long before Trump's presidency, becoming a crucial partner to the federal government as it phased out the space shuttle program. If Musk reverses on his decision to keep Dragon in commission, experts say it could debilitate the U.S. space program 'If such threats were carried out, it would be catastrophic,' said space policy expert Mark Whittington, adding later, 'Without SpaceX, we're back to being dependent on the Russians.' NASA has increasingly relied on SpaceX for its infrastructure, including the Dragon capsule, which is the only U.S. system capable of getting crews to the International Space Station. Russia's Souyuz capsules, the Associated Press reported, are the only other way to get crews to the space station. While both Trump and Musk have much to lose from a war, some Republicans veterans aren't ruling out the chance of a reconciliation. 'There's always the possibility that Trump is serious about this, but I think if you take the 'Art of the Deal' seriously, he is often maximally negotiating,' said GOP strategist Chris Johnson. The feud appeared to cool slightly Friday morning, as Musk seemingly agreed with a post from hedge fund manager Bill Ackman, who suggested the pair 'should make peace for the benefit of our great country.' But Trump has shown no desire to talk to Musk despite reports the two might speak on the phone. 'I won't be speaking to him for a while, I guess, but I wish him well,' Trump told CNN's Dana Bash on Friday. Tesla's stock partially recovered amid hopes of a détente, rising 5 percent. 'If Musk is able to sue for peace and the onus is on him to make peace with Trump, then it'll be a blip in the screen and their bromance will be restored,' Seitchik told The Hill. However, he added, 'If this call goes poorly and this continues to escalate, then certainly Trump will look for every bit of leverage to inflict pain on Elon Musk and his businesses.'
Business Upturn
9 hours ago
- Business Upturn
ProZenith Launches Natural Supplement Formulated for Weight Management Support
By GlobeNewswire Published on June 7, 2025, 06:50 IST Aurora, June 06, 2025 (GLOBE NEWSWIRE) — ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part of a balanced and active lifestyle. Manufactured in the United States in a facility that is FDA-registered and GMP-certified, the product is now available through official online channels. ProZenith is intended for individuals pursuing support for general weight management and overall well-being. Its formulation includes select ingredients chosen to align with healthy routines and support individuals seeking help managing non-hunger-related snacking behaviors. Each purchase of ProZenith is covered by a 60-day refund policy, reflecting the company's customer-first return assurance framework. All ProZenith supplements are manufactured without genetically modified ingredients and adhere to U.S. quality standards. Production takes place in an FDA-registered facility that complies with current Good Manufacturing Practices (cGMP). ProZenith is currently available through the company's official online platform at with multiple purchase options provided for convenience. About ProZenith ProZenith develops nutritional supplements designed to support individuals on their wellness journeys. The company emphasizes high-quality manufacturing, transparency, and customer satisfaction as it continues to expand its product offerings for health-conscious consumers. For customer support inquiries, contact: [email protected] Disclaimer: This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Media Contact: Company: ProZenith ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 19655 E 35th Dr #100, Aurora, CO 80011 Email: [email protected] [email protected] Order Phone Support: (925) 217-7353 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
